News and Events

May 3, 2013

Zebrafish Make a Splash in FDA Research

by FDA Consumer Health Information / U.S. Food and Drug Administartion

A recent Food and Drug Administration (FDA) Consumer Update was written describing the use of zebrafish as a model for predictive toxicology.
Click to read the Consumer Update

Researchers at the FDA's National Center for Toxicological Research (NCTR) are utilizing zebrafish in a number of different projects, including investigating the biological effects of copper nanoparticles, and examining the potential of drugs to cause endocrine disruption. After reviewing the article, please feel free to contact Lampire to see how our zebrafish embryo culture (ZEC) screening service can assist you in determining the teratogenic liability of your compound of interest. This assay, along with our rat whole embryo culture (rWEC) assay, are just two examples of the continuing Lampire initiative to provide cost effective in vitro teratogenicity screening assays that conform to the principle of reducing, refining, and replacing animals used in research.